KRKA, TOVARNA ZDRAVIL D.D. - 2023 Unaudited Semi-Annual Report of the Krka group and Krka, d. d., Novo mesto

Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:

1. H1 2023 Unaudited Interim Report of the Krka Group and Krka Novo mesto.pdf 2023 Unaudited Semi-Annual Report of the Krka group and Krka, d. d., Novo mesto
   
2. Press Release.pdf Press Release
   

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 26 / 2023

Date of issue: 2023-07-20

Short name of the issuer

KRKA

Subject

2023 Unaudited Semi-Annual Report of the Krka group and Krka, d. d., Novo mesto

Official market - legal basis

art. 56. 1. 2 of Act on Public Offering.

Unofficial market - legal basis

Contents of the report:

Based on the provisions of the Rules of the Ljubljana Stock Exchange, d. d., Ljubljana and Article 136 of the Market in Financial Instruments Act, Krka, d. d., Novo mesto publishes the 2023 Unaudited Semi-Annual Report of the Krka group and Krka, d. d., Novo mesto.


The report will be published on the Company's website (www.krka.biz) from 20 July 2023 onwards, for a period of at least 10 years.

Annexes

File Description

H1 2023 Unaudited Interim Report of the Krka Group and Krka Novo mesto.pdfH1 2023 Unaudited Interim Report of the Krka Group and Krka Novo mesto.pdf 2023 Unaudited Semi-Annual Report of the Krka group and Krka, d. d., Novo mesto

Press Release.pdfPress Release.pdf Press Release

KRKA, TOVARNA ZDRAVIL D.D.

(fullname of the issuer)

KRKA Farmaceutyczny (far)

(short name of the issuer) (sector according to clasification of the WSE in Warsow)

8501 Nove Mesto

(post code) (city)

Smarjeska 6

(street) (number)

[phone] [phone]

(phone number) (fax)

(e-mail) (web site)

nie dotyczy

(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date Name Position / Function Signature

2023-07-20 Jože Colarič President of the Management Board and CEO